| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |